<?xml version="1.0" encoding="UTF-8"?>
<p id="p0040">The following section provides brief personal background, perspectives and references provided by the three corresponding authors.
 <boxed-text id="dtbox1">
  <caption>
   <title>Ling-Pei Ho: Respiratory epithelium during influenza virus infection</title>
  </caption>
  <p id="p0045"/>
  <p id="p0050">The specific role of respiratory epithelium in the host defence against influenza has been less studied compared to the immune system as a whole, yet its coverage of the lungs is massive and it is the very first contact that the virus has with the host. Indeed it can be viewed as the first point in the innate immune machinery against influenza virus infection. Prof Ho and her team were originally interested in how the immune response in the lungs shaped lung immune-mediated lung diseases like sarcoidosis; particularly in how CD1d-restricted natural killer T cell (NKT) regulated lung immune responses 
   <xref rid="bib1" ref-type="bibr">[1]</xref>. They used influenza as a model to understand lung immune responses 
   <xref rid="bib2" ref-type="bibr">[2]</xref>, 
   <xref rid="bib3" ref-type="bibr">[3]</xref>, 
   <xref rid="bib4" ref-type="bibr">[4]</xref> and how non-conventional T cells like NKT and MAIT cells controlled anti-viral responses but soon found that myeloid cells are key to immunepathology during murine influenza virus infections 
   <xref rid="bib5" ref-type="bibr">[5]</xref>, 
   <xref rid="bib6" ref-type="bibr">[6]</xref>. During the recent pandemic, Prof Ho led an investigation into the immune correlates of severe disease in patients who had particularly poor outcome, a study that again implicated the monocyte-macrophage pathway in lung immunepathology during influenza infection 
   <xref rid="bib7" ref-type="bibr">[7]</xref>. Her team also contributed to studies which identified IFITM3 as a key anti-viral ISG in IAV infections 
   <xref rid="bib8" ref-type="bibr">[8]</xref>, 
   <xref rid="bib9" ref-type="bibr">[9]</xref>. Prof Ho is currently based at the MRC Human Immunology Unit, Oxford, and her group now focuses on how monocytes and macrophages contribute to injury and (dys) repair of the alveolar epithelium.
  </p>
  <ref-list id="cebib0010">
   <title>References</title>
   <ref id="bib1">
    <label>1</label>
    <element-citation publication-type="journal" id="sref1">
     <person-group person-group-type="author">
      <name>
       <surname>Ho</surname>
       <given-names>L.P.</given-names>
      </name>
      <name>
       <surname>Urban</surname>
       <given-names>B.C.</given-names>
      </name>
      <name>
       <surname>Thickett</surname>
       <given-names>D.R.</given-names>
      </name>
      <name>
       <surname>Davies</surname>
       <given-names>R.J.O.</given-names>
      </name>
      <name>
       <surname>McMichael</surname>
       <given-names>A.J.</given-names>
      </name>
     </person-group>
     <article-title>Deficiency of a subset of T-cells with immunoregulatory properties in sarcoidosis</article-title>
     <source>Lancet</source>
     <volume>365</volume>
     <year>2005</year>
     <fpage>1062</fpage>
     <lpage>1072</lpage>
     <pub-id pub-id-type="pmid">15781102</pub-id>
    </element-citation>
   </ref>
   <ref id="bib2">
    <label>2</label>
    <element-citation publication-type="journal" id="sref2">
     <person-group person-group-type="author">
      <name>
       <surname>Wegmann</surname>
       <given-names>F.</given-names>
      </name>
      <name>
       <surname>Gartlan</surname>
       <given-names>K.</given-names>
      </name>
      <name>
       <surname>Brinckmann</surname>
       <given-names>S.</given-names>
      </name>
      <name>
       <surname>Harandi</surname>
       <given-names>A.</given-names>
      </name>
      <name>
       <surname>Coccia</surname>
       <given-names>M.</given-names>
      </name>
      <name>
       <surname>Hillson</surname>
       <given-names>W.</given-names>
      </name>
     </person-group>
     <article-title>Polyethyleneimine is a potent Irf-3-dependent mucosal adjuvant for glycoprotein antigens that elicits protective immunity to viral infection</article-title>
     <source>Nat Biotechnol</source>
     <volume>30</volume>
     <year>2012</year>
     <fpage>883</fpage>
     <lpage>887</lpage>
     <pub-id pub-id-type="pmid">22922673</pub-id>
    </element-citation>
   </ref>
   <ref id="bib3">
    <label>3</label>
    <element-citation publication-type="journal" id="sref3">
     <person-group person-group-type="author">
      <name>
       <surname>Zhao</surname>
       <given-names>Y.H.</given-names>
      </name>
      <name>
       <surname>Zhang</surname>
       <given-names>L.</given-names>
      </name>
      <name>
       <surname>Denney</surname>
       <given-names>L.</given-names>
      </name>
      <name>
       <surname>Young</surname>
       <given-names>D.</given-names>
      </name>
      <name>
       <surname>Powell</surname>
       <given-names>T.</given-names>
      </name>
      <name>
       <surname>Peng</surname>
       <given-names>Y.C.</given-names>
      </name>
     </person-group>
     <article-title>High levels of virus-specific CD4+ T cells predict severe pandemic influenza a virus infection</article-title>
     <source>Am J Respir Crit Care Med</source>
     <volume>186</volume>
     <year>2012</year>
     <fpage>1292</fpage>
     <lpage>1297</lpage>
     <pub-id pub-id-type="pmid">23087026</pub-id>
    </element-citation>
   </ref>
   <ref id="bib4">
    <label>4</label>
    <element-citation publication-type="journal" id="sref4">
     <person-group person-group-type="author">
      <name>
       <surname>Ho</surname>
       <given-names>L.P.</given-names>
      </name>
      <name>
       <surname>Denney</surname>
       <given-names>L.</given-names>
      </name>
      <name>
       <surname>Luhn</surname>
       <given-names>K.</given-names>
      </name>
      <name>
       <surname>Teoh</surname>
       <given-names>D.</given-names>
      </name>
      <name>
       <surname>Clelland</surname>
       <given-names>C.</given-names>
      </name>
      <name>
       <surname>McMichael</surname>
       <given-names>A.J.</given-names>
      </name>
     </person-group>
     <article-title>Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection</article-title>
     <source>Eur J Immunol</source>
     <volume>38</volume>
     <year>2008</year>
     <fpage>1913</fpage>
     <lpage>1922</lpage>
     <pub-id pub-id-type="pmid">18521958</pub-id>
    </element-citation>
   </ref>
   <ref id="bib5">
    <label>5</label>
    <element-citation publication-type="journal" id="sref5">
     <person-group person-group-type="author">
      <name>
       <surname>Kok</surname>
       <given-names>W.L.</given-names>
      </name>
      <name>
       <surname>Denney</surname>
       <given-names>L.</given-names>
      </name>
      <name>
       <surname>Benam</surname>
       <given-names>K.</given-names>
      </name>
      <name>
       <surname>Clelland</surname>
       <given-names>C.</given-names>
      </name>
      <name>
       <surname>McMichael</surname>
       <given-names>A.J.</given-names>
      </name>
      <name>
       <surname>Ho</surname>
       <given-names>L.P.</given-names>
      </name>
     </person-group>
     <article-title>Invariant NKT cells decrease immunepathology in lethal influenza A virus infection by reducing accumulation of inflammatory monocytes in the lungs</article-title>
     <source>J Leukoc Biol</source>
     <volume>91</volume>
     <year>2012</year>
     <fpage>357</fpage>
     <lpage>359</lpage>
     <pub-id pub-id-type="pmid">22003207</pub-id>
    </element-citation>
   </ref>
   <ref id="bib6">
    <label>6</label>
    <element-citation publication-type="journal" id="sref6">
     <person-group person-group-type="author">
      <name>
       <surname>van Wilgenburg</surname>
       <given-names>B.</given-names>
      </name>
      <name>
       <surname>Scherwitzl</surname>
       <given-names>I.</given-names>
      </name>
      <name>
       <surname>Hutchinson</surname>
       <given-names>E.</given-names>
      </name>
      <name>
       <surname>Leng</surname>
       <given-names>T.</given-names>
      </name>
      <name>
       <surname>Kurioka</surname>
       <given-names>A.</given-names>
      </name>
      <name>
       <surname>Kulicke</surname>
       <given-names>C.</given-names>
      </name>
     </person-group>
     <article-title>MAIT cells are activated during human viral infections</article-title>
     <source>Nat Commun</source>
     <volume>7</volume>
     <year>2016</year>
     <fpage>11653</fpage>
     <pub-id pub-id-type="pmid">27337592</pub-id>
    </element-citation>
   </ref>
   <ref id="bib7">
    <label>7</label>
    <element-citation publication-type="journal" id="sref7">
     <person-group person-group-type="author">
      <name>
       <surname>Cole</surname>
       <given-names>S.L.</given-names>
      </name>
      <name>
       <surname>Dunning</surname>
       <given-names>J.</given-names>
      </name>
      <name>
       <surname>Kok</surname>
       <given-names>W.L.</given-names>
      </name>
      <name>
       <surname>Benam</surname>
       <given-names>K.H.</given-names>
      </name>
      <name>
       <surname>Benlahrech</surname>
       <given-names>A.</given-names>
      </name>
      <name>
       <surname>Repapi</surname>
       <given-names>E.</given-names>
      </name>
     </person-group>
     <article-title>M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza</article-title>
     <source>J Clin Invest Insight</source>
     <volume>6</volume>
     <year>2017</year>
     <fpage>e91868</fpage>
    </element-citation>
   </ref>
   <ref id="bib8">
    <label>8</label>
    <element-citation publication-type="journal" id="sref8">
     <person-group person-group-type="author">
      <name>
       <surname>Everitt</surname>
       <given-names>R.</given-names>
      </name>
      <name>
       <surname>Clare</surname>
       <given-names>S.</given-names>
      </name>
      <name>
       <surname>John</surname>
       <given-names>S.P.</given-names>
      </name>
      <name>
       <surname>John</surname>
       <given-names>S.P.</given-names>
      </name>
      <name>
       <surname>Wash</surname>
       <given-names>R.S.</given-names>
      </name>
      <name>
       <surname>Smith</surname>
       <given-names>S.E.</given-names>
      </name>
     </person-group>
     <article-title>IFITM3 restricts the morbidity and mortality associated with influenza</article-title>
     <source>Nature</source>
     <volume>484</volume>
     <year>2012</year>
     <fpage>519</fpage>
     <pub-id pub-id-type="pmid">22446628</pub-id>
    </element-citation>
   </ref>
   <ref id="bib9">
    <label>9</label>
    <element-citation publication-type="journal" id="sref9">
     <person-group person-group-type="author">
      <name>
       <surname>Zhang</surname>
       <given-names>Y.H.</given-names>
      </name>
      <name>
       <surname>Zhao</surname>
       <given-names>Y.</given-names>
      </name>
      <name>
       <surname>Li</surname>
       <given-names>N.</given-names>
      </name>
      <name>
       <surname>Peng</surname>
       <given-names>Y.C.</given-names>
      </name>
      <name>
       <surname>Giannoulatou</surname>
       <given-names>E.</given-names>
      </name>
      <name>
       <surname>Jin</surname>
       <given-names>R.H.</given-names>
      </name>
     </person-group>
     <article-title>IFITM3 rs12252-C is associated with disease severity in acute, pandemic influenza A H1N1/09 infected Chinese individuals</article-title>
     <source>Nat Commun</source>
     <volume>4</volume>
     <year>2013</year>
     <fpage>1418</fpage>
     <pub-id pub-id-type="pmid">23361009</pub-id>
    </element-citation>
   </ref>
  </ref-list>
 </boxed-text>
 <boxed-text id="dtbox2">
  <caption>
   <title>Shin-Ru Shih: Centennial review of influenza in Taiwan</title>
  </caption>
  <p id="p0055"/>
  <p id="p0060">Shin-Ru Shih obtained her bachelor degree in Medical Technology and master degree in Biochemistry from National Taiwan University and her Ph.D. in Biochemistry and Molecular Biology from Rutgers University, New Jersey, USA. She established a Molecular Virology Laboratory at Chang Gung University in 1996 and was appointed Medical Director in Clinical Virology Laboratory, Chang Gung Memorial Hospital in 1998. She also started the Research Center for Emerging Viral Infections at Chang Gung University in 2009 as centre director.</p>
  <p id="p0065">Dr. Shih began influenza virus research from her Ph.D. study under the supervision of Professor Robert M. Krug 
   <xref rid="bib10" ref-type="bibr">[1]</xref>, 
   <xref rid="bib11" ref-type="bibr">[2]</xref>. Her papers regarding influenza virus surveillance have been widely discussed in influenza control and surveillance 
   <xref rid="bib12" ref-type="bibr">[3]</xref>, 
   <xref rid="bib13" ref-type="bibr">[4]</xref>. Her team identified several therapeutic targets for development of antiviral strategies 
   <xref rid="bib14" ref-type="bibr">[5]</xref>, 
   <xref rid="bib15" ref-type="bibr">[6]</xref>.
  </p>
  <ref-list id="cebib0015">
   <title>References</title>
   <ref id="bib10">
    <label>1</label>
    <element-citation publication-type="journal" id="sref10">
     <person-group person-group-type="author">
      <name>
       <surname>Shih</surname>
       <given-names>S.R.</given-names>
      </name>
      <name>
       <surname>Nemeroff</surname>
       <given-names>M.E.</given-names>
      </name>
      <name>
       <surname>Krug</surname>
       <given-names>R.M.</given-names>
      </name>
     </person-group>
     <article-title>The choice of alternative 5 splice sites in influenza virus M1 mRNA is regulated by the viral polymerase complex</article-title>
     <source>Proc Natl Acad Sci USA</source>
     <volume>92</volume>
     <year>1995</year>
     <fpage>6324</fpage>
     <lpage>6328</lpage>
     <pub-id pub-id-type="pmid">7541537</pub-id>
    </element-citation>
   </ref>
   <ref id="bib11">
    <label>2</label>
    <element-citation publication-type="journal" id="sref11">
     <person-group person-group-type="author">
      <name>
       <surname>Shih</surname>
       <given-names>S.R.</given-names>
      </name>
      <name>
       <surname>Krug</surname>
       <given-names>R.M.</given-names>
      </name>
     </person-group>
     <article-title>Novel exploitation of a nuclear function by influenza virus : the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells</article-title>
     <source>EMBO J</source>
     <volume>15</volume>
     <year>1996</year>
     <fpage>5415</fpage>
     <lpage>5427</lpage>
     <pub-id pub-id-type="pmid">8895585</pub-id>
    </element-citation>
   </ref>
   <ref id="bib12">
    <label>3</label>
    <element-citation publication-type="journal" id="sref12">
     <person-group person-group-type="author">
      <name>
       <surname>Chen</surname>
       <given-names>G.W.</given-names>
      </name>
      <name>
       <surname>Chang</surname>
       <given-names>S.C.</given-names>
      </name>
      <name>
       <surname>Mok</surname>
       <given-names>C.K.</given-names>
      </name>
      <name>
       <surname>Lo</surname>
       <given-names>Y.L.</given-names>
      </name>
      <name>
       <surname>Wang</surname>
       <given-names>J.Y.</given-names>
      </name>
      <name>
       <surname>Chiang</surname>
       <given-names>C.</given-names>
      </name>
     </person-group>
     <article-title>Genomic signatures of human versus avian influenza a viruses</article-title>
     <source>Emerg Infect Dis</source>
     <volume>12</volume>
     <year>2006</year>
     <fpage>1353</fpage>
     <lpage>1360</lpage>
     <pub-id pub-id-type="pmid">17073083</pub-id>
    </element-citation>
   </ref>
   <ref id="bib13">
    <label>4</label>
    <element-citation publication-type="journal" id="sref13">
     <person-group person-group-type="author">
      <name>
       <surname>Chen</surname>
       <given-names>G.W.</given-names>
      </name>
      <name>
       <surname>Shih</surname>
       <given-names>S.R.</given-names>
      </name>
     </person-group>
     <article-title>Genomic signatures of pandemic (H1N1) 2009 influenza virus</article-title>
     <source>Emerg Infect Dis</source>
     <volume>15</volume>
     <year>2009</year>
     <fpage>1897</fpage>
     <lpage>1903</lpage>
     <pub-id pub-id-type="pmid">19998748</pub-id>
    </element-citation>
   </ref>
   <ref id="bib14">
    <label>5</label>
    <element-citation publication-type="journal" id="sref14">
     <person-group person-group-type="author">
      <name>
       <surname>Chen</surname>
       <given-names>M.F.</given-names>
      </name>
      <name>
       <surname>Weng</surname>
       <given-names>K.F.</given-names>
      </name>
      <name>
       <surname>Huang</surname>
       <given-names>S.Y.</given-names>
      </name>
      <name>
       <surname>Liu</surname>
       <given-names>Y.C.</given-names>
      </name>
      <name>
       <surname>Tseng</surname>
       <given-names>S.N.</given-names>
      </name>
      <name>
       <surname>David</surname>
       <given-names>M.</given-names>
      </name>
     </person-group>
     <article-title>Pretreatment with a heat-killed probiotic modulates monocyte chemoattractant protein-1 and reduces the pathogenicity of influenza and enterovirus 71 infections</article-title>
     <source>Mucosal Immunol</source>
     <volume>10</volume>
     <year>2017</year>
     <fpage>215</fpage>
     <lpage>227</lpage>
     <pub-id pub-id-type="pmid">27072606</pub-id>
    </element-citation>
   </ref>
   <ref id="bib15">
    <label>6</label>
    <element-citation publication-type="journal" id="sref15">
     <person-group person-group-type="author">
      <name>
       <surname>Kuo</surname>
       <given-names>S.M.</given-names>
      </name>
      <name>
       <surname>Chen</surname>
       <given-names>C.J.</given-names>
      </name>
      <name>
       <surname>Chang</surname>
       <given-names>S.C.</given-names>
      </name>
      <name>
       <surname>Liu</surname>
       <given-names>T.J.</given-names>
      </name>
      <name>
       <surname>Chen</surname>
       <given-names>Y.S.</given-names>
      </name>
      <name>
       <surname>Huang</surname>
       <given-names>S.Y.</given-names>
      </name>
     </person-group>
     <article-title>Inhibition of avian influenza A virus replication in human cells by host restriction factor TUFM is correlated with autophagy</article-title>
     <source>MBio</source>
     <volume>8</volume>
     <year>2017</year>
     <fpage>e00481-17</fpage>
     <pub-id pub-id-type="pmid">28611246</pub-id>
    </element-citation>
   </ref>
  </ref-list>
 </boxed-text>
 <boxed-text id="dtbox3">
  <caption>
   <title>Andrew J McMichael: Legacy of the influenza pandemic 1918: The host T cell response</title>
  </caption>
  <p id="p0070"/>
  <p id="p0075">The wealth of knowledge gained on the influenza virus, stimulated by the 1918 pandemic and subsequent discovery of the virus, stimulated research into the immunology of this infection. Early studies focused on the antibody response, how this might be optimized by vaccination and how antibodies contributed to antigenic drift and shift in the virus. Then in the 1970s Zinkernagel and Doherty made the major discovery that CD8
   <sup>+</sup> T cell recognition of virus infected cells was restricted by class I molecules of the major histocompatibility complex (MHC) 
   <xref rid="bib17" ref-type="bibr">[1]</xref>. The mechanisms behind this were revealed twelve years later when Townsend et al. showed that influenza specific T cells recognized peptides bound to class I MHC molecules 
   <xref rid="bib18" ref-type="bibr">[2]</xref>, subsequently beautifully demonstrated in crystal structures by Pamela Bjorkman and colleagues 
   <xref rid="bib19" ref-type="bibr">[3]</xref>. These experiments showed that T cells could recognize internal proteins of virus infected cells, with profound implications for understanding cellular immunity to infections and cancers heralding the development of vaccines and novel therapies.
  </p>
  <ref-list id="cebib0015c">
   <title>References</title>
   <ref id="bib17">
    <label>1</label>
    <element-citation publication-type="journal" id="sref17">
     <person-group person-group-type="author">
      <name>
       <surname>Zinkernagel</surname>
       <given-names>R.M.</given-names>
      </name>
      <name>
       <surname>Doherty</surname>
       <given-names>P.C.</given-names>
      </name>
     </person-group>
     <article-title>Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system</article-title>
     <source>Nature</source>
     <volume>248</volume>
     <year>1974</year>
     <fpage>701</fpage>
     <lpage>702</lpage>
     <pub-id pub-id-type="pmid">4133807</pub-id>
    </element-citation>
   </ref>
   <ref id="bib18">
    <label>2</label>
    <element-citation publication-type="journal" id="sref18">
     <person-group person-group-type="author">
      <name>
       <surname>Townsend</surname>
       <given-names>A.R.</given-names>
      </name>
      <name>
       <surname>Rothbard</surname>
       <given-names>J.</given-names>
      </name>
      <name>
       <surname>Gotch</surname>
       <given-names>F.M.</given-names>
      </name>
      <name>
       <surname>Bahadur</surname>
       <given-names>G.</given-names>
      </name>
      <name>
       <surname>Wraith</surname>
       <given-names>D.</given-names>
      </name>
      <name>
       <surname>McMichael</surname>
       <given-names>A.J.</given-names>
      </name>
     </person-group>
     <article-title>The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides</article-title>
     <source>Cell</source>
     <volume>44</volume>
     <year>1986</year>
     <fpage>959</fpage>
     <lpage>968</lpage>
     <pub-id pub-id-type="pmid">2420472</pub-id>
    </element-citation>
   </ref>
   <ref id="bib19">
    <label>3</label>
    <element-citation publication-type="journal" id="sref19">
     <person-group person-group-type="author">
      <name>
       <surname>Bjorkman</surname>
       <given-names>P.J.</given-names>
      </name>
      <name>
       <surname>Saper</surname>
       <given-names>M.A.</given-names>
      </name>
      <name>
       <surname>Samraoui</surname>
       <given-names>B.</given-names>
      </name>
      <name>
       <surname>Bennett</surname>
       <given-names>W.S.</given-names>
      </name>
      <name>
       <surname>Strominger</surname>
       <given-names>J.L.</given-names>
      </name>
      <name>
       <surname>Wiley</surname>
       <given-names>D.C.</given-names>
      </name>
     </person-group>
     <article-title>Structure of the human class I histocompatibility antigen, HLA-A2</article-title>
     <source>Nature</source>
     <volume>329</volume>
     <year>1987</year>
     <fpage>506</fpage>
     <lpage>512</lpage>
     <pub-id pub-id-type="pmid">3309677</pub-id>
    </element-citation>
   </ref>
  </ref-list>
 </boxed-text>
</p>
